The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> April 7, 2015

Interview with the President and CEO: Cytori Therapeutics Inc. (CYTX)

Hedrick, Marc H.
Dr. Marc H. Hedrick is President and CEO of Cytori Therapeutics Inc. Dr. Hedrick was trained as a general, vascular and craniofacial surgeon who left his clinical practice and tenured faculty appointment at UCLA in 2003 after founding StemSource, Inc. StemSource later became Cytori, a leading U.S. public company specializing in stem cell therapies. Previously, Dr. Hedrick was a tenured Associate Professor of Surgery and Pediatrics at the University of California, Los Angeles — UCLA. While at UCLA, Dr. Hedrick also directed the Laboratory of Regenerative Bioengineering and Repair. Dr. Hedrick’s research encompassed many areas, including tissue engineering, stem cell biology and fetal surgery. Dr. Hedrick has published over 200 scientific abstracts, papers and book chapters, and received research funding from a variety of private and governmental agencies, including the National Institutes of Health. In addition, he has 23 published or issued patents around the world, and both he and his work have been featured prominently in numerous leading periodicals and media outlets. Dr. Hedrick obtained his undergraduate degree from Southern Methodist University, his medical degree from the University of Texas Southwestern Medical School and his Master of Business Administration from the UCLA Anderson School of Management. He completed residencies in plastic surgery at UCLA, and general and vascular surgery at the University of Oklahoma. He has also completed fellowships in craniofacial surgery at University of Pittsburgh and fetal surgery at the University of California, San Francisco. Dr. Hedrick resides in Encinitas, California, is married to Tracey Carole Hedrick and has two children, Catherine and Marc II.    Profile
TWST: Could you please begin with a brief overview of Cytori’s structure and focus?

Dr. Hedrick: Cytori was founded in 1996. I’m one of the founders of a cell therapy

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy